MyAverix Finance
F · Healthcare
PROTALIX BIOTHERAP.DL-01 (PBDA)
Biotechnology
PROTALIX BIOTHERAP.DL-01 (PBDA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $146.64M, P/E ratio is 18.00, net margin is -12.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PBDA
PROTALIX BIOTHERAP.DL-01 (PBDA) — FAQ
What is PROTALIX BIOTHERAP.DL-01's market cap?
PROTALIX BIOTHERAP.DL-01 (PBDA) has a reported market cap of $146.64M (data as of 2026-03-30).
What is PBDA's P/E ratio?
The price-to-earnings (P/E) ratio for PROTALIX BIOTHERAP.DL-01 (PBDA) is 18.00 (data as of 2026-03-30).
Does PROTALIX BIOTHERAP.DL-01 pay a dividend?
Dividend yield is not available in the current snapshot for PROTALIX BIOTHERAP.DL-01 (PBDA). Check the MyAverix Finance app for the latest dividend data.
What sector is PROTALIX BIOTHERAP.DL-01 in?
PROTALIX BIOTHERAP.DL-01 (PBDA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PBDA listed on?
PBDA is listed on F.
What is PROTALIX BIOTHERAP.DL-01's net margin?
PROTALIX BIOTHERAP.DL-01 (PBDA) reports a net margin of -12.5% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.